Mucoepidermoid carcinoma natural history

Jump to: navigation, search

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma natural history

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma natural history

CDC on Mucoepidermoid carcinoma natural history

Mucoepidermoid carcinoma natural history in the news

Blogs on Mucoepidermoid carcinoma natural history

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: , Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

If left untreated, patients with mucoepidermoid carcinoma may progress to develop sentinel metastasis to adjacent lymph nodes. Common complications of mucoepidermoid carcinoma include facial deformity, dysphagia, and local lymph node metastasis. Prognosis will generally depend on the clinical stage, tumor size, and histological grade. The overall recurrence rate will depend on the stage. Low grade tumors have a 90-98% survival rate and a low rate of local recurrence.

Natural History

  • The majority of patients with mucoepidermoid carcinoma are initially asymptomatic.
  • Symptoms usually develop in the second or fifth decade of life, and initially patients complain of swallowing problems that are increased upon mastication.
  • If left untreated, patients with mucoepidermoid carcinoma may progress to develop sentinel lymph node metastasis.
  • Mode of metastasis may be[1]

Complications

  • Common complications of mucoepidermoid carcinoma include:[2]

Prognosis

  • Prognosis will generally depend on the clinical stage, tumor size, and histological grade.[2]
  • The overall recurrence rate depends on the stage of the tumor.[2][3]
  • Low grade tumors have a 90-98% survival rate and a low rate of local recurrence.
  • High grade tumors have a 30-54% survival rate, and a high local recurrence rate.[3]
  • The 5-year survival rate of patients with mucoepidermoid carcinoma is:[4]
  • Stage I 75%
  • Stage II 59%
  • Stage III 57%
  • Stage IV 28%
  • Overall incidence of lymph node involvement ranges from 18–28%.
  • When distant metastases develop in patients with minor salivary gland tumours the average survival is 2.3 years
  • Tumours of the major salivary glands is 2.6 years.[5][6][7]

[8][9]

References

  1. Asuquo, ME; Nwagbara, VI; Umana, AN; Bassey, G; Ugbem, T (2013). "Giant Mucoepidermoid Carcinoma of the Parotid Gland: A Case Report and Review of Literature". Journal of Clinical & Experimental Oncology. 02 (01). doi:10.4172/2324-9110.1000103. ISSN 2324-9110.
  2. 2.0 2.1 2.2 Plambeck K, Friedrich RE, Schmelzle R (1996). "Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients". J Craniomaxillofac Surg. 24 (3): 133–9. PMID 8842902.
  3. 3.0 3.1 Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY (1990). "Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy". Arch. Otolaryngol. Head Neck Surg. 116 (3): 290–3. PMID 2306346.
  4. Wealey, W. V., Perzin, K. H. and Smith, L. (1970), Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment. Cancer, 26: 368–388. doi: 10.1002/1097-0142(197008)26:2<368::AID-CNCR2820260219>3.0.CO;2-K
  5. Spiro RH, Huvos AG, Berk R, Strong EW (October 1978). "Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases". Am. J. Surg. 136 (4): 461–8. PMID 707726.
  6. Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD, Faratzis G, Lagogiannis GA, Katsilieris I, Patsouris E (February 2007). "Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients". Oral Oncol. 43 (2): 130–6. doi:10.1016/j.oraloncology.2006.03.001. PMID 16857410.
  7. Clode, Ana Luisa; Fonseca, Isabel; Santos, J. Rosa; Soares, Jorge (1991). "Mucoepidermoid carcinoma of the salivary glands: A reappraisal of the influence of tumor differentiation on prognosis". Journal of Surgical Oncology. 46 (2): 100–106. doi:10.1002/jso.2930460207. ISSN 0022-4790.
  8. Spitz, M. R.; Batsakis, J. G. (1984). "Major Salivary Gland Carcinoma: Descriptive Epidemiology and Survival of 498 Patients". Archives of Otolaryngology - Head and Neck Surgery. 110 (1): 45–49. doi:10.1001/archotol.1984.00800270049013. ISSN 0886-4470.
  9. Rapidis, Alexander D.; Givalos, Nikolaos; Gakiopoulou, Hariklia; Stavrianos, Spyros D.; Faratzis, Gregory; Lagogiannis, George A.; Katsilieris, Ioannis; Patsouris, Efstratios (2007). "Mucoepidermoid carcinoma of the salivary glands". Oral Oncology. 43 (2): 130–136. doi:10.1016/j.oraloncology.2006.03.001. ISSN 1368-8375.

Linked-in.jpg